A Message from the Scientific Director
I wish to welcome you all to the NIDA Intramural Research Program (IRP) Web Site. This site contains descriptive information and representative recent publications of IRP Independent Investigators. We hope you will find it useful for learning about IRP research programs and for opportunities for participation in basic and clinical drug abuse research.
What is NIDA?
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), is dedicated to understanding the causes, consequences and treatment of drug abuse. To meet this challenge, NIDA runs a research facility (Intramural Research Program, IRP) in East Baltimore whose mission is to better understand drug abuse and the many factors which may contribute to this enormous societal problem. We at NIDA understand the personal devastation caused by drug abuse and addiction, as well as its destruction of families and communities. Through research we hope to better understand the causes of this problem and develop new and more effective treatments.
The mission of the Intramural Research Program (IRP) of the National Institute on Drug Abuse is to conduct state-of-the-art research on basic mechanisms that underlie drug abuse and addiction, and to develop new methods for the treatment of drug abuse and addiction. Research is supported at the molecular, genetic, cellular, animal, and clinical levels and is conceptually integrated, highly innovative, and focused on major problems in the field. The long-term goal of the research is to better understand the biological and behavioral factors contributing to initiation, maintenance, and elimination of drug abuse and addiction (and associated diseases), and to translate this knowledge into improved strategies for preventing, treating, and reducing the negative consequences for the individual and for society caused by drug abuse and addiction. An important aspect of the program is the training of young investigators and career development of more experienced investigators in basic and clinical sciences related to drug abuse research.